How Continuous Monitoring Impacts Neuromuscular Disease Research According to the most recent data available, inherited neuromuscular diseases affect only 0.048% of the population , a figure that explains some of the clinical and logistical difficulty of studying them well. Patients, who may already experience symptoms like progressive muscle weakness, mobility loss, and fatigue from respiratory or cardiac complications, are usually scattered across the country and may have difficulty participating in clinical research even when they have strong motivation to do so. Continuous monitoring with